.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

RA after Vioxx: What Now?

January 10, 2005

Treating rheumatoid arthritis is challenging enough as it is without the latest studies linking COX-2 inhibitors, often used as adjunct therapy, with an increased heart risk. These studies have left many RA patients and physicians a bit apprehensive about continuous high-dose therapy.